Whole-body hyperthermia and a subthreshold dose of citalopram act synergistically to induce antidepressant-like behavioral responses in adolescent rats

Prog Neuropsychopharmacol Biol Psychiatry. 2017 Oct 3;79(Pt B):162-168. doi: 10.1016/j.pnpbp.2017.06.006. Epub 2017 Jun 12.

Abstract

Background: Open and randomized, double blind, placebo-controlled clinical trials have demonstrated clinical efficacy of infrared whole-body hyperthermia in treatment of major depressive disorder (MDD). Demonstration of antidepressant-like behavioral effects of whole-body hyperthermia in preclinical rodent models would provide further support for the clinical use of infrared whole-body hyperthermia for the treatment of MDD, and would provide additional opportunities to explore underlying mechanisms.

Methods: Adolescent male Wistar rats were habituated daily for 7days to an incubator (23°C, 15min), then exposed, 24h later, to an 85-min period of whole-body hyperthermia (37°C) or control conditions (23°C), with or without pretreatment with a subthreshold dose of the selective serotonin reuptake inhibitor, citalopram (5mg/kg, s.c., 23h, 5h, and 1h before behavioral testing in a 5-min forced swim test). Rectal temperature was monitored daily and immediately before and after the forced swim test to determine the relationship between body temperature and antidepressant-like behavioral responses.

Results: Whole-body hyperthermia and citalopram independently increased body temperature and acted synergistically to induce antidepressant-like behavioral responses, as measured by increased swimming and decreased immobility in the absence of any effect on climbing behaviors in the forced swim test, consistent with a serotonergic mechanism of action.

Conclusions: Preclinical data support use of infrared whole-body hyperthermia in the treatment of MDD.

Keywords: Alternative; Antidepressant; Complementary; Integrative health care; Serotonin; Whole-body heating.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Animals
  • Antidepressive Agents / pharmacology*
  • Body Temperature / drug effects
  • Body Weight / drug effects
  • Citalopram / pharmacology*
  • Depressive Disorder, Major / physiopathology
  • Depressive Disorder, Major / therapy*
  • Disease Models, Animal
  • Hyperthermia, Induced*
  • Male
  • Rats, Wistar
  • Rectum
  • Selective Serotonin Reuptake Inhibitors / pharmacology*

Substances

  • Antidepressive Agents
  • Serotonin Uptake Inhibitors
  • Citalopram